Literature DB >> 31698006

Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study.

Marie-Lisa Eich1, Maria Del Carmen Rodriguez Pena1, Lauren Schwartz2, Carlos Prieto Granada1, Soroush Rais-Bahrami3, Giovanna Giannico4, Belkiss Murati Amador5, Andres Matoso5, Jennifer B Gordetsky6.   

Abstract

Our objective was to evaluate the pathologic features and clinical outcomes in cases of invasive penile squamous cell carcinoma (SCC) and the association with p16 immunohistochemistry (IHC) and human papilloma virus (HPV) in situ hybridization (ISH). A retrospective multi-institutional database search was conducted for invasive SCC of the penis diagnosed between 2007 and 2018 that had undergone surgical resection. Pathologic features, p16 IHC, and HPV ISH were investigated with clinical outcomes. A total of 102 patients were included in the study. The average age was 63 ± 13.3 years. Based on histology, 46% of tumors displayed an HPV-related subtype, whereas p16 was positive in 52% of all cases. Tumor histology correlated well with p16 positivity (P < .001), and p16 IHC accurately predicted the presence of HPV in 25/26 (96%) cases. On multivariate analysis, perineural invasion was associated with local disease recurrence (P = .02), whereas lymphovascular invasion was associated with progression to metastatic disease (P = .002) and increased overall mortality (P = .02). Urethral involvement was also associated with increased overall mortality (P = .02). In addition, HPV-related tumors based on histologic features correlated with lower rates of metastatic disease (P = .007). HPV is a common cause of penile SCC and can be diagnosed by tumor histology and confirmed by overexpression of p16 on IHC. The presence of lymphovascular invasion, perineural invasion, and urethral involvement are poor prognostic indicators, whereas HPV-related tumors based on histology may have lower risk for metastatic disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPV; Immunohistochemistry; Pathology; Penis; Squamous cell carcinoma; p16

Mesh:

Substances:

Year:  2019        PMID: 31698006     DOI: 10.1016/j.humpath.2019.09.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.

Authors:  Sang Kyum Kim; Jang-Hee Kim; Jae Ho Han; Nam Hoon Cho; Se Joong Kim; Sun Il Kim; Seol Ho Choo; Ji Su Kim; Bumhee Park; Ji Eun Kwon
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-26       Impact factor: 4.553

2.  Incidence trends and survival outcomes of penile squamous cell carcinoma: evidence from the Surveillance, Epidemiology and End Results population-based data.

Authors:  Feng Qi; Xiyi Wei; Yuxiao Zheng; Xiaohan Ren; Xiao Li; Erkang Zhao
Journal:  Ann Transl Med       Date:  2020-11

3.  National trends and survival outcomes of penile squamous cell carcinoma based on human papillomavirus status.

Authors:  Juan Chipollini; Grant Pollock; Chiu-Hsieh Hsu; Ken Batai; Alejandro Recio-Boiles; Benjamin R Lee
Journal:  Cancer Med       Date:  2021-10-10       Impact factor: 4.452

4.  Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care.

Authors:  Luiza Dorofte; Diane Grélaud; Michelangelo Fiorentino; Francesca Giunchi; Costantino Ricci; Tania Franceschini; Mattia Riefolo; Sabina Davidsson; Jessica Carlsson; Gabriella Lillsunde Larsson; Mats G Karlsson
Journal:  Virchows Arch       Date:  2021-12-10       Impact factor: 4.535

Review 5.  Imaging for the Initial Staging and Post-Treatment Surveillance of Penile Squamous Cell Carcinoma.

Authors:  Samuel J Galgano; John C Norton; Kristin K Porter; Janelle T West; Soroush Rais-Bahrami
Journal:  Diagnostics (Basel)       Date:  2022-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.